Evidence-based guidelines based on a large-scale sleep apnea study demonstrate WatchPAT’s efficiency and accuracy
Cardio
First Patient in Biosense Webster’s Multi-Electrode RF Balloon Catheter Study
Multicenter study will evaluate balloon ablation catheter for safety and effectiveness in achieving pulmonary vein isolation in paroxysmal AF treatment
Enrollment Complete in Thermocool Smarttouch® SF Catheter US IDE Study
Persistent Paroxysmal Atrial Fibrillation in focus for heart rhythm specialist
First-in-Man Study Demonstrates Safety and Efficacy of SELUTION™ DCB in Long Lesions
Findings confirm the efficacy of the SELUTION sirolimus-coated technology
Endologix Completes ELEVATE IDE Clinical Study Enrollment
Endovascular stent graft study promises clinical results later this year
FDA Nod for CardiAmp Cell Therapy IDE Trial in Chronic Myocardial Ischemia
“It is a step towards developing a new treatment strategy that could have tremendous benefit for patients with refractory angina”
First Patient Enrolled in U.S. LAA Stroke Study
Biosense Webster, Inc. launches U.S. study to evaluate the safety and efficacy of the WaveCrest® Left Atrial Appendage Occlusion System
“Exceptional” Six-Week Stent Results Offer Hope to Severe Tricuspid Regurgitation Patients
Two implantations of GATE™ Atrioventricular Valved Stent (AVS) in compassionate cases
Abbott’s MitraClip First Transcatheter Mitral Valve Repair Device Approved in Japan
Japanese study data underpins approval
HighLife Closes €12.3 Million Financing Round
Plans see acceleration of the company’s clinical and R&D program
New Funding Will Fuel Claret Medical’s U.S. Plans for Sentinel® Cerebral Protection System
Company closes $14.5million funding round
Green Light for BioCardia Study Following Interim Safety Analysis
Phase 3 260 patient stem cell therapy clinical trial back on track
Stem Cells Safely Delivered with BioCardia Helix™
Phase II trial confirms safety for mesenchymal stem cells delivered with steerable, two-catheter system from within the chamber of the heart
Cerebral Protection System Prevents One Stroke or Death for Every 21 TAVR Patients
New study says Sentinel Cerebral Protection System significantly reduces stroke and mortality associated with Transcatheter Aortic Valve Replacement.
U.S. Launch of AtriCure’s AtriClip® PRO•V™ Device
“early experience and feedback from customers utilizing the device to treat patients has been excellent”
Sentry Vena Cava Filter Yields Zero Pulmonary Embolisms at 12 Months
Irish device company, Novate Medical sees compelling results presented at VIVA 2017